Results of the first clinical trial of Australia’s ‘second generation’ bionic eye have demonstrated ‘substantial improvement’ in four participants’ functional vision, daily activities and quality of life over a period of more than two and a half years.

Led by the Centre for Eye Research Australia, Bionics Institute, University of Melbourne and Royal Victorian Eye and Ear Hospital, the trial findings add to interim results which showed that the second-generation bionic eye developed by Australian company Bionic Vision Technologies provided rapid improvements for four patients with blindness caused the genetic eye condition retinitis pigmentosa.

Exercise & Sports Science Australia (ESSA) this week in Adelaide convened the Activate Conference billed as “where science meets inspiration”, bringing together the latest research, breakthrough ideas and real-world applications from across exercise and sports science.  

Pelvic Floor Dysfunction – Lived experience, symptoms, diagnosis and treatment options